Human MDM2/ACTFS/hdm2 ORF/cDNA clone-Lentivirus plasmid (NM_002392.5)
Cat. No.: pGMLV000680
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human MDM2/ACTFS/hdm2 Lentiviral expression plasmid for MDM2 lentivirus packaging, MDM2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
MDM2/HDM2/MDM2/ACTFS products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLV000680 |
| Gene Name | MDM2 |
| Accession Number | NM_002392.5 |
| Gene ID | 4193 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 1494 bp |
| Gene Alias | ACTFS,hdm2,HDMX |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGTGAGGAGCAGGCAAATGTGCAATACCAACATGTCTGTACCTACTGATGGTGCTGTAACCACCTCACAGATTCCAGCTTCGGAACAAGAGACCCTGGTTAGACCAAAGCCATTGCTTTTGAAGTTATTAAAGTCTGTTGGTGCACAAAAAGACACTTATACTATGAAAGAGGTTCTTTTTTATCTTGGCCAGTATATTATGACTAAACGATTATATGATGAGAAGCAACAACATATTGTATATTGTTCAAATGATCTTCTAGGAGATTTGTTTGGCGTGCCAAGCTTCTCTGTGAAAGAGCACAGGAAAATATATACCATGATCTACAGGAACTTGGTAGTAGTCAATCAGCAGGAATCATCGGACTCAGGTACATCTGTGAGTGAGAACAGGTGTCACCTTGAAGGTGGGAGTGATCAAAAGGACCTTGTACAAGAGCTTCAGGAAGAGAAACCTTCATCTTCACATTTGGTTTCTAGACCATCTACCTCATCTAGAAGGAGAGCAATTAGTGAGACAGAAGAAAATTCAGATGAATTATCTGGTGAACGACAAAGAAAACGCCACAAATCTGATAGTATTTCCCTTTCCTTTGATGAAAGCCTGGCTCTGTGTGTAATAAGGGAGATATGTTGTGAAAGAAGCAGTAGCAGTGAATCTACAGGGACGCCATCGAATCCGGATCTTGATGCTGGTGTAAGTGAACATTCAGGTGATTGGTTGGATCAGGATTCAGTTTCAGATCAGTTTAGTGTAGAATTTGAAGTTGAATCTCTCGACTCAGAAGATTATAGCCTTAGTGAAGAAGGACAAGAACTCTCAGATGAAGATGATGAGGTATATCAAGTTACTGTGTATCAGGCAGGGGAGAGTGATACAGATTCATTTGAAGAAGATCCTGAAATTTCCTTAGCTGACTATTGGAAATGCACTTCATGCAATGAAATGAATCCCCCCCTTCCATCACATTGCAACAGATGTTGGGCCCTTCGTGAGAATTGGCTTCCTGAAGATAAAGGGAAAGATAAAGGGGAAATCTCTGAGAAAGCCAAACTGGAAAACTCAACACAAGCTGAAGAGGGCTTTGATGTTCCTGATTGTAAAAAAACTATAGTGAATGATTCCAGAGAGTCATGTGTTGAGGAAAATGATGATAAAATTACACAAGCTTCACAATCACAAGAAAGTGAAGACTATTCTCAGCCATCAACTTCTAGTAGCATTATTTATAGCAGCCAAGAAGATGTGAAAGAGTTTGAAAGGGAAGAAACCCAAGACAAAGAAGAGAGTGTGGAATCTAGTTTGCCCCTTAATGCCATTGAACCTTGTGTGATTTGTCAAGGTCGACCTAAAAATGGTTGCATTGTCCATGGCAAAACAGGACATCTTATGGCCTGCTTTACATGTGCAAAGAAGCTAAAGAAAAGGAATAAGCCCTGCCCAGTATGTAGACAACCAATTCAAATGATTGTGCTAACTTATTTCCCCTAG |
| ORF Protein Sequence | MVRSRQMCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T00176-Ab | Anti-MDM2 monoclonal antibody |
| Target Antigen | GM-Tg-g-T00176-Ag | MDM2 protein |
| ORF Viral Vector | pGMLP005735 | Human MDM2 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000680 | Human MDM2 Lentivirus plasmid |
| ORF Viral Vector | pGMLP-SPh-001 | Human MDM2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-SPh-141 | Human MDM2 Adenovirus plasmid |
| ORF Viral Vector | pGMPC001312 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC004812 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC004828 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC004926 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP005735 | Human MDM2 Lentivirus particle |
| ORF Viral Vector | vGMLV000680 | Human MDM2 Lentivirus particle |
| ORF Viral Vector | vGMLP-SPh-001 | Human MDM2 Lentivirus particle |
| ORF Viral Vector | vGMAP-SPh-141 | Human MDM2 Adenovirus particle |
Target information
| Target ID | GM-T00176 |
| Target Name | MDM2/HDM2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
4193 |
| Gene ID |
100052084 (Equus caballus), 17246 (Mus musculus), 314856 (Rattus norvegicus), 403693 (Canis lupus familiaris) 4193 (Homo sapiens), 493939 (Felis catus), 540378 (Bos taurus), 718284 (Macaca mulatta) |
| Gene Symbols & Synonyms | MDM2,Mdm2,edm2,Mdm-2,1700007J15Rik,HDMX,LSKB,hdm2,ACTFS |
| Target Alternative Names | 1700007J15Rik,ACTFS,Double minute 2 protein (Hdm2),E3 ubiquitin-protein ligase Mdm2,HDM2,HDMX,LSKB,MDM2,Mdm-2,Mdm2,Oncoprotein Mdm2,RING-type E3 ubiquitin transferase Mdm2,edm2,hdm2,p53-binding protein Mdm2 |
| Uniprot Accession |
P23804,P56950,P56951,Q00987,Q7YRZ8
Additional SwissProt Accessions: P56951,P23804,P56950,Q00987,Q7YRZ8 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer, Breast Cancer |
| Disease from KEGG | Endocrine resistance, FoxO signaling pathway, p53 signaling pathway, PI3K-Akt signaling pathway, Cellular senescence, C-type lectin receptor signaling pathway, Thyroid hormone signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Epstein-Barr virus infection, Pathways in cancer, Proteoglycans in cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia |
| Gene Ensembl | ENSECAG00000013604, ENSMUSG00000020184, ENSCAFG00845016387, ENSG00000135679, ENSBTAG00000010422, ENSMMUG00000055447 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


